Riskpilot← Back to searchSign inGet full accessDOKTOR TYSNES AS
ASActiveOrg 924393149Karin Nilsen Tysnes Ilaveien 8, 1358 JarGeneral medical practice activities · NACE 8621Est. 20201 employees
Revenue 2024
NOK 3,9M
+4% vs 2023
EBITDA margin
43.1%
+7% vs 2023
Equity ratio
1.7%
Financial strength
Net profit 2024
NOK 1,3M
+8% vs 2023
| Revenue | NOK 3,9M | +4% |
| EBITDA | NOK 1,7M | +7% |
| Net profit | NOK 1,3M | +8% |
| Total assets | NOK 2,4M | +33% |
| Equity | NOK 40K | -84% |
| Employees | 1 | — |
Legal name
DOKTOR TYSNES AS
Org number
924393149
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
13. januar 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet/drive allmennlegepraksis. Kjøp, utleie/drift og salg av eiendom og det som derved følger med. Videre kjøp/salg av aksjer og andre verdipapirer og hva som står i forbindelse med dette.
Address
Karin Nilsen Tysnes Ilaveien 8, 1358 Jar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 059 | 3 199 | 3 335 | 3 721 | 3 858 |
| Staff expenses | −978 | −840 | −917 | −997 | −986 |
| EBITDA | 1 030 | 1 337 | 1 333 | 1 560 | 1 663 |
| Depreciation & amort. | −27 | −27 | −27 | −27 | −0 |
| EBIT | 1 003 | 1 309 | 1 306 | 1 533 | 1 663 |
| Net financials | −4 | −1 | −16 | 1 | −0 |
| Profit before tax | 999 | 1 308 | 1 290 | 1 534 | 1 662 |
| Tax | 218 | 288 | 284 | 337 | 366 |
| Net profit | 781 | 1 020 | 1 005 | 1 197 | 1 296 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 515 | 2 455 | 2 741 | 1 784 | 2 366 |
| Equity | 801 | 1 041 | 47 | 243 | 40 |
| Long-term debt | 318 | 971 | 1 226 | 32 | 215 |
| Short-term debt | 395 | 442 | 1 468 | 1 509 | 2 111 |
| Total debt | 713 | 1 414 | 2 694 | 1 541 | 2 326 |
EBITDA margin
43.1%
This company
15.8%
Market median
+173% vs market
20202024
Equity ratio
1.7%
This company
38.2%
Market median
-96% vs market
20202024
Return on equity
3277.4%
This company
18.4%
Market median
+17712% vs market
20202024
Net profit margin
33.6%
This company
8.1%
Market median
+315% vs market
20202024
Asset turnover
1.63×
This company
1.12×
Market median
+46% vs market
20202024
Debt / equity
58.82×
This company
0.62×
Market median
-9387% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DOKTOR TYSNES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Nilsen Tysnes | Chairman | 0 companies |
| Pål Ove Sukka | Board of Directors | 0 companies |